Understanding your biopsy report

Number of Cores Positive — and What It Means

When you open your biopsy report, two sets of numbers describe the extent of what was found: how many of the needle samples contained cancer, and how much of each sample was affected. These sit alongside the Gleason grade and together give your urologist a picture of where the cancer is and how much tissue appears to be involved.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Cores are the needle samples — A biopsy takes multiple small cylinders of tissue, each called a core, from different zones of the prostate.
Positive means cancer was found there — A positive core is one where the pathologist identified cancer cells in that sample under a microscope.
Percentage shows how much of each core — Each positive core carries a percentage stating what fraction of that cylinder's length contained cancer.
Grade and volume are read together — Neither the core count nor the percentage alone decides anything — your urologist reads them alongside the Gleason grade.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

Your biopsy report states how many needle samples, called cores, contain cancer cells and what percentage of each core is involved. Your urologist uses these numbers alongside the Gleason grade to understand how much of the prostate appears to be affected. The combination of grade and volume shapes the treatment options they discuss with you.

What does a positive core mean on a prostate biopsy report?

During a prostate biopsy, the urologist takes multiple small cylinders of tissue from different zones of the prostate. Each cylinder is called a core. A positive core is one where the pathologist found cancer cells when examining it under a microscope.

Your report states the result as a fraction — the number of cores that tested positive out of the total number taken. Each positive core also carries a percentage: how much of that cylinder's length was occupied by cancer cells.

Your urologist reads the core count, the percentage involvement, and the Gleason grade together. Interpreting what any specific combination means for your situation is a clinical judgement your urologist makes — not something a report number alone can tell you.

What the terms on your biopsy report mean

Core: A single needle sample of prostate tissue. A biopsy takes several cores from mapped locations across the gland so that different zones are sampled.
Positive core: A core in which the pathologist found cancer cells. A negative core showed no cancer in that sample — though this reflects that sample, not the entire zone.
Cores positive / total cores: The fraction of all samples that contained cancer. It gives an indication of how widely distributed the cancer appears to be across the prostate.
Percentage core involvement: For each positive core, the estimated proportion of that cylinder's length occupied by cancer. Sometimes reported per core and sometimes as an average across all positive cores.
Bilateral involvement: Cancer found on both the left and right sides of the prostate. Unilateral means cancer was found on one side only. Both are recorded because the distinction is relevant to some treatment planning decisions.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What to look for in this section of your report

The total number of cores taken — this is the denominator in the positive/total fraction.
The number of cores found positive for cancer.
The percentage involvement stated for each positive core.
Whether involvement is noted as unilateral (one side) or bilateral (both sides).
The Gleason grade assigned to each positive core — grade and volume are always read together.

Questions families often ask about core involvement

Does more cores positive always mean more serious cancer?

Not automatically. Grade and volume are both relevant, and they are weighted differently depending on the full clinical picture. A small number of cores positive at a high Gleason grade can represent more clinically significant disease than a higher count at a low grade. Your urologist places both pieces of information within established risk stratification frameworks — such as those published by NCCN or ESMO — to reach a risk category, not by using the core count alone.

Why does the percentage of each core matter separately from the count?

Two patients can have the same number of positive cores but very different amounts of cancer within them. If each core shows only a small patch of involvement, the overall volume of disease is lower than when cores are extensively involved throughout their length. This distinction is relevant when active surveillance is being assessed, because published surveillance criteria typically set limits on both the number of positive cores and the percentage involvement per core. Your urologist applies those criteria to your specific result.

What does bilateral involvement mean for my treatment?

Bilateral involvement means cancer was found on both sides of the prostate. It is one of several factors your urologist considers in planning. For some surgical approaches it affects whether a nerve-sparing technique is possible. For radiation planning it informs where dose is directed. Being bilateral does not automatically move a result into a higher risk category on its own — Gleason grade and overall volume are also part of that assessment — but your team will factor it in.

Can a biopsy miss cancer in the negative cores?

Yes. A biopsy samples representative areas rather than every cell in the prostate. A negative core confirms no cancer was found in that sample, not that no cancer exists in that zone. This limitation is one reason MRI is commonly used before or alongside biopsy — it helps direct sampling toward areas that appear abnormal on imaging and improves the chances that the biopsy reflects the true picture. If there are questions about sampling adequacy, your urologist will address them.

Should we be concerned if only one core is positive?

A single positive core is still a cancer diagnosis and requires careful review. However, a low count is a relevant part of the clinical picture alongside the grade and percentage involvement. Some patients with a single minimally involved, low-grade core are candidates for active surveillance rather than immediate treatment — others are not, because other elements of the result move the risk assessment. Your urologist will explain which situation applies to your specific report.

Explore 114 more Waiting For and Understanding Your Report topics

Gleason & Prostate Biopsy Reporting

Cytology Reporting Systems

Grade, Differentiation & Mitotic Index

Margins, LVI and PNI

Reading Your Histopathology Report

Staging on a Biopsy Report

Waiting for Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

How many cores are taken in a prostate biopsy?

The number varies by centre and clinical situation. A standard systematic biopsy takes several cores from mapped locations across the prostate; some biopsies are targeted to areas identified on MRI and may take fewer, or combine targeted and systematic sampling. Your report will state the total number taken — that is the denominator you read alongside the number of positive cores.

What does it mean if all my positive cores have low percentage involvement?

Low percentage involvement per core means that in each positive sample, only a small portion of the cylinder's length contained cancer. This is one indicator of lower-volume disease and is relevant when active surveillance is being assessed. However, what it means for your management depends on the Gleason grade and the full clinical picture. Your urologist reads all the elements together, not any one number in isolation.

My report gives a percentage for each core. Do I add them together?

No. The percentage for each core describes that individual sample — it is not intended to be summed across cores. Some reports include an average or maximum across all positive cores, but those are calculated by the pathologist and stated in the report. Reading the figures as if they combine arithmetically does not produce a meaningful result and is not how your urologist uses the information.

Is there a number of positive cores that rules out active surveillance?

Published guidelines reference criteria that include core numbers, but applying those criteria to a specific result is a clinical act, not a calculation a patient makes from the report. The criteria also account for Gleason grade and percentage involvement alongside the count. Your urologist will tell you directly whether active surveillance is being considered and what the reasoning is — which is more useful than a general threshold from a guidelines summary.

What if cancer was found in a core taken from the seminal vesicles?

Seminal vesicle involvement is reported separately and carries a different clinical significance from cores taken from the prostate itself. It is one of the factors that influences staging and treatment planning. If you are unsure whether any of your cores came from the seminal vesicles, ask your urologist to walk through the report section by section.

Should we get a second pathology opinion on the biopsy cores?

A second opinion is a reasonable step when there is uncertainty about the Gleason grade, when the result is unexpected given the clinical picture, or when the diagnosis will lead to a major treatment decision. Many specialist cancer centres review outside pathology as routine. If you are considering it, ask your urologist whether the slides can be sent to another institution's genitourinary pathology team.

Full index